Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_assertion description "[Further analysis of one of the proteins encoded by a MIDAS-containing mRNA, namely PDPK-1 (3-phosphoinositide dependent protein kinase-1), which is an important regulator of mammalian target of rapamycin/PP2A signaling, showed that PDPK-1 protein synthesis is significantly reduced in cells from an OS patient compared with an age-matched control and can be rescued by functional MID1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_assertion evidence source_evidence_literature NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_assertion SIO_000772 21930711 NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_assertion wasDerivedFrom befree-20150227 NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_assertion wasGeneratedBy ECO_0000203 NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP614811.RAPNQbL-br2fz1aKjd6eaJ3-p0hmZVVixYgaP7niBUPzE130_provenance.